SBTX

SkinBiotherapeutics Plc

Skinbiotherapeutics PLC Notice of interim results

Skinbiotherapeutics PLC (LON:SBTX), a life sciences company focused on skin health, will publish its interim results for the six months to 31 December 2017 on 21 February 2018.   SkinBioTherapeutics is

SkinBiotherapeutics Plc

Skinbiotherapeutics Appointment of Joint Broker

Skinbiotherapeutics PLC (LON:SBTX), a life science company focused on skin health, announced today the appointment of Northland Capital Partners to act as the Company’s Joint Corporate Broker, alongside Turner Pope Investments,